Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study

World Journal of Gastroenterology

Volumn 19, Issue 27, 2013, Pages 4325-4333

  Principi, Mariabeatrice ^a   Di Leo, Alfredo ^a   Pricci, Maria ^a   Scavo, Maria Principia ^a   Guido, Raffaella ^a   Tanzi, Sabina ^a   Piscitelli, Domenico ^a   Pisani, Antonio ^a   Ierardi, Enzo ^b   Comelli, Maria Cristina ^c   Barone, Michele ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c R and D CMD Pharma Limited   (United Kingdom)

Author keywords

Estrogen receptor ; Estrogen receptor ; Insoluble fibers; Phytoestrogens; Sporadic adenomatous polyposis; Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; MESSENGER RNA; OAT FIBER EXTRACT; PHYTOESTROGEN; PLACEBO; PLANT EXTRACT; SECOISOLARICIRESINOL; SILYBUM MARIANUM EXTRACT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; COLON ADENOMA; COLONOSCOPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIETARY FIBER; DOUBLE BLIND PROCEDURE; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INSOLUBLE FIBER; MALE; NICK END LABELING; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84880396232     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i27.4325     Document Type: Article

References (34)

1. Koo JH, Leong RW. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 2010; 25: 33-42 [PMID: 19874446 DOI: 10.1111/j.1440-1746.2009.05992]
2. Rennert G, Rennert HS, Pinchev M, Lavie O, Gruber SB. Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol 2009; 27: 4542-4547 [PMID: 19704062 DOI: 10.1200/JCO.2009.22.0764]
3. Woodson K, Lanza E, Tangrea JA, Albert PS, Slattery M, Pinsky J, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A. Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst 2001; 93: 1799-1805 [PMID: 11734596 DOI: 10.1093/jnci/93.23.1799]
4. Solimando R, Bazzoli F, Ricciardiello L. Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment? Best Pract Res Clin Gastroenterol 2011; 25: 555-568 [PMID: 22122771 DOI: 10.1016/j.bpg.2011.09.004]
5. Chang EC, Frasor J, Komm B, Katzenellenbogen BS. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 2006; 147: 4831-4842 [PMID: 16809442 DOI: 10.1210/ en.2006-0563]
6. Francavilla A, Di Leo A, Polimeno L, Conte D, Barone M, Fanizza G, Chiumarulo C, Rizzo G, Rubino M. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 1987; 93: 1301-1306 [PMID: 3678749]
7. Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005; 14: 17-21 [PMID: 15944762]
8. Di Leo A, Messa C, Cavallini A, Linsalata M. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1: 1-12 [PMID: 12476778]
9. Hsu HH, Cheng SF, Wu CC, Chu CH, Weng YJ, Lin CS, Lee SD, Wu HC, Huang CY, Kuo WW. Apoptotic effects of over-expressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner. Chin J Physiol 2006; 49: 110-116 [PMID: 16830793]
10. Helguero LA, Faulds MH, Gustafsson JA, Haldosén LA. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 2005; 24: 6605-6616 [PMID: 16007178 DOI: 10.1038/sj.onc.1208807]
11. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal 2008; 6: e003 [PMID: 18301783 DOI: 10.1621/nrs.06003]
12. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001; 61: 632-640 [PMID: 11212261]
13. Di Leo A, Barone M, Maiorano E, Tanzi S, Piscitelli D, Marangi S, Lofano K, Ierardi E, Principi M, Francavilla A. ERbeta expression in large bowel adenomas: implications in colon carcinogenesis. Dig Liver Dis 2008; 40: 260-266 [PMID: 18093886 DOI: 10.1016/j.dld.2007.10.018]
14. Barone M, Scavo MP, Papagni S, Piscitelli D, Guido R, Di Lena M, Comelli MC, Di Leo A. ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis. Scand J Gastroenterol 2010; 45: 1320-1328 [PMID: 20446826 DOI: 10.3109/00365521]
15. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour' s dedifferentiation. Eur J Cancer 2003; 39: 1251-1258 [PMID: 12763213 DOI: 10.1016/S0959-8049(03)00239-9]
16. Volate SR, Davenport DM, Muga SJ, Wargovich MJ. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 2005; 26: 1450-1456 [PMID: 15831530 DOI: 10.1093/carcin/bgi089]
17. Kohno H, Suzuki R, Noguchi R, Hosokawa M, Miyashita K, Tanaka T. Dietary conjugated linolenic acid inhibits azoxymethane- induced colonic aberrant crypt foci in rats. Jpn J Cancer Res 2002; 93: 133-142 [PMID: 11856476]
18. Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side. Anticancer Res 2006; 26: 4457-4498 [PMID: 17201169]
19. Singh RP, Raina K, Sharma G, Agarwal R. Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial- mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice. Clin Cancer Res 2008; 14: 7773-7780 [PMID: 19047104 DOI: 10.1158/1078-0432. CCR-08-1309]
20. Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, Papagni S, Guido R, Maiorano E, Ingravallo G, Comelli MC, Francavilla A, Di Leo A. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Carcinogenesis 2010; 31: 269-274 [PMID: 19945967 DOI: 10.1093/carcin/bgp275]
21. Egeberg R, Olsen A, Loft S, Christensen J, Johnsen NF, Overvad K, Tjønneland A. Intake of wholegrain products and risk of colorectal cancers in the Diet, Cancer and Health cohort study. Br J Cancer 2010; 103: 730-734 [PMID: 20733580 DOI: 10.1038/sj.bjc.6605806]
22. Kuijsten A, Hollman PC, Boshuizen HC, Buijsman MN, van't Veer P, Kok FJ, Arts IC, Bueno-de-Mesquita HB. Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study. Am J Epidemiol 2008; 167: 734-742 [PMID: 18192676 DOI: 10.1093/aje/kwm349]
23. Milder IE, Kuijsten A, Arts IC, Feskens EJ, Kampman E, Hollman PC, Van't Veer P. Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population. J Nutr 2007; 137: 1266-1271 [PMID: 17449591]
24. Rajamanickam S, Velmurugan B, Kaur M, Singh RP, Agarwal R. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Res 2010; 70: 2368-2378 [PMID: 20215518 DOI: 10.1158/0008-5472.CAN-09-3249]
25. LIPKIN M. CELL REPLICATION IN THE GASTROINTESTINAL TRACT OF MAN. Gastroenterology 1965; 48: 616-624 [PMID: 14277358]
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174 [PMID: 843571]
27. Cavallini A, Messa C, Pricci M, Caruso ML, Barone M, Di Leo A. Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer. Dig Dis Sci 2002; 47: 2720-2728 [PMID: 12498292]
28. Seidlová-Wuttke D, Becker T, Christoffel V, Jarry H, Wuttke W. Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats. J Steroid Biochem Mol Biol 2003; 86: 179-188 [PMID: 14568570 DOI: 10.1016/S0960-0760(03)00270-X]
29. El-Shitany NA, Hegazy S, El-Desoky K. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. Phytomedicine 2010; 17: 116-125 [PMID: 19577454 DOI: 10.1016/j.phymed.2009.05.012]
30. Begum AN, Nicolle C, Mila I, Lapierre C, Nagano K, Fukushima K, Heinonen SM, Adlercreutz H, Rémésy C, Scalbert A. Dietary lignins are precursors of mammalian lignans in rats. J Nutr 2004; 134: 120-127 [PMID: 14704303]
31. Giroux V, Lemay F, Bernatchez G, Robitaille Y, Carrier JC. Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice. Int J Cancer 2008; 123: 303-311 [PMID: 18464259 DOI: 10.1002/ijc.23532]
32. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 1999; 96: 1858-1862 [PMID: 10051559 DOI: 10.1073/pnas.96.5.1858]
33. Reid G, Denger S, Kos M, Gannon F. Human estrogen receptor- alpha: regulation by synthesis, modification and degradation. Cell Mol Life Sci 2002; 59: 821-831 [PMID: 12088282]
34. Amorim JP, Chuffa LG, Teixeira GR, Mendes LO, Fioruci BA, Martins OA, Mello W, Anselmo-Franci JA, Pinheiro PF, Martinez M, Martinez FE. Variations in maternal care alter corticosterone and 17beta-estradiol levels, estrous cycle and folliculogenesis and stimulate the expression of estrogen receptors alpha and beta in the ovaries of UCh rats. Reprod Biol Endocrinol 2011; 9: 160 [PMID: 22192617 DOI: 10.1186/1477-7827-9-160]